Expression of Fatty Acid–Binding Protein-3 in Gastrointestinal Stromal Tumors and Its Significance for Prognosis

FABP3 is a member of the fatty acid–binding protein (FABP) family, whose role in various cancers has been reported in the past. However, little is known about the role that FABP3 plays in gastrointestinal stromal tumors (GISTs). FABP3 expression was analyzed in 119 patients with GISTs using immunohi...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of surgical research 2021-04, Vol.260, p.462-466
Main Authors: Chen, Xi, Hu, Shi-Liu, Feng, Ying, Li, Peng, Mao, Qin-Sheng, Xue, Wan-Jiang
Format: Article
Language:English
Subjects:
Fatty acid–binding protein-3 (FABP3)
Gastrointestinal stromal tumor (GISTs)
Immunohistochemistry
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:FABP3 is a member of the fatty acid–binding protein (FABP) family, whose role in various cancers has been reported in the past. However, little is known about the role that FABP3 plays in gastrointestinal stromal tumors (GISTs). FABP3 expression was analyzed in 119 patients with GISTs using immunohistochemistry and tissue microarrays to interrogate the relationship between expression and prognosis. Kaplan–Meier analysis was used to calculate patient survival rates using complete follow-up data and to evaluate the potential prognostic value of FABP3 using Cox regression analysis. FABP3-positive signals were detected as brown particles located in the cytoplasm using immunohistochemistry. Among the 119 tissue samples, we observed high FABP3 expression in 64 and low or negative expression in 55. Immunohistochemical analyses suggested that FABP3 expression was significantly correlated with tumor size (P = 0.006), mitotic index (P = 0.016), gross classification (P = 0.048), and AFIP-Miettinen risk classification (P = 0.007). Multiple logistic regression analysis showed that the expression of FABP3 was significantly associated with tumor size (P = 0.021). Kaplan–Meier survival curves showed that patients with GISTs with low expression of FABP3 and classified with a very low to moderate AFIP-Miettinen risk had better prognosis. Multivariate analysis further showed that high expression of FABP3 (P = 0.017) was significantly associated with poor 5-year overall survival. High FABP3 expression has a prognostic value for patients with GISTs.
ISSN:0022-4804
1095-8673
DOI:10.1016/j.jss.2020.11.003